Related Experiment Video

Updated: Apr 9, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

20.7K

Sclerostin and DKK1: new players in renal bone and vascular disease

Pieter Evenepoel1, Patrick D'Haese2, Vincent Brandenburg3

  • 1Laboratory of Nephrology, Department of Immunology and Microbiology, KU Leuven, and Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.

Kidney International
|June 18, 2015
PubMed

Insights

The Wnt-β-catenin pathway is crucial for bone health and is disrupted in chronic kidney disease-mineral bone disorder (CKD-MBD). Inhibitors like Dickkopf-related protein 1 (DKK1) and sclerostin play a role, but their clinical significance requires further study.

Area of Science:

  • Bone biology and mineral metabolism
  • Endocrinology and nephrology
  • Signaling pathway research

Background:

  • The Wnt-β-catenin pathway is vital for skeletal development and bone mass maintenance.
  • This pathway is tightly regulated by inhibitors, including Dickkopf-related protein 1 (DKK1) and sclerostin.
  • Dysregulated Wnt-β-catenin signaling is implicated in chronic kidney disease-associated bone and mineral disorder (CKD-MBD).

Purpose of the Study:

  • To review the role of Wnt-β-catenin signaling and its inhibitors in CKD-MBD.
  • To discuss the potential involvement of DKK1 and sclerostin in kidney-vasculature-bone interactions.
  • To highlight the challenges and future directions in targeting Wnt inhibitors for CKD-MBD treatment.

Main Methods:

  • Literature review and synthesis of existing research on Wnt signaling in bone and CKD-MBD.
  • Analysis of studies investigating circulating levels of DKK1 and sclerostin in CKD patients.
  • Evaluation of therapeutic strategies involving Wnt inhibitor neutralization.

Main Results:

  • Conflicting results exist regarding the clinical correlation of circulating DKK1 and sclerostin levels in CKD-MBD.
  • Biological variability and analytical issues contribute to inconsistencies in study findings.
  • Wnt inhibitors like sclerostin may impact mineralization in both bone and vasculature.

Conclusions:

  • Further research is needed to understand the determinants of Wnt inhibitors in CKD.
  • The efficacy and safety of novel pharmaceuticals targeting Wnt inhibitors require thorough evaluation.
  • Neutralizing antibodies against Wnt inhibitors present a potential therapeutic avenue for CKD-MBD, but caution is advised.

More Related Videos

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

2.7K
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.2K

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.8K
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
9.4K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.6K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
6.1K
What is the Skeletal System?01:02

What is the Skeletal System?

Overview
59.2K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
41.2K